UK PR pitch could portend US acquisitions for AstraZeneca

Share this article:
AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.

The company is hearing pitches from multiple City of London communications agencies including incumbent Brunswick, FD, Finsbury and Tulchan Communications, all of which specialize in financial PR.

The business is worth a sum in the low six figures in fees, though project work around mergers and acquisitions could pad that out considerably, reported PRWeek UK. The review comes amid speculation that the company could buy Shire and beef up its US operations through acquisitions. 
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.